Bhavnish PARIKH,Krishnaswamy YELESWARAM,Dilip P. MODI,Trupti SHETH
申请号：
MX2016001639
公开号：
MX2016001639A
申请日:
2014.08.06
申请国别(地区):
MX
年份:
2016
代理人:
摘要：
This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl }-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidi n-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto.La presente invención se refiere a formas de dosificación de liberación prolongada que comprenden {1-{1[3-fluoro-2-(trifluorome til)isonicotinoil]piperidin-4-il}-3-[4-(7H-pirrolo[2,3-d]pirimidi n-4-il)-1H-pirazol-1-il]azetidin-3-il}acetonitrilo o una sal farmacéuticamente aceptable de este y dosis y métodos relacionadas con estas.
